Use of triptans during pregnancy? With caution!
Drugs
Fetal death
Intra-uterine growth retardation
Pregnancy
Triptans
Journal
Therapie
ISSN: 1958-5578
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544
Informations de publication
Date de publication:
Historique:
received:
18
10
2019
revised:
22
10
2019
accepted:
12
12
2019
pubmed:
12
1
2020
medline:
21
10
2021
entrez:
12
1
2020
Statut:
ppublish
Résumé
We report cases, registered in the French national pharmacovigilance database, of fetal death and intrauterine growth retardation in women exposed to triptans during pregnancy. Triptans have vasoconstrictive properties and we wonder about their responsibility for these side effects. The use of triptans and other drugs exhibiting vasoconstrictive properties in pregnant women requires a careful benefits/risks evaluation.
Identifiants
pubmed: 31924306
pii: S0040-5957(19)30189-1
doi: 10.1016/j.therap.2019.12.007
pii:
doi:
Substances chimiques
Tryptamines
0
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
477-478Informations de copyright
Copyright © 2019 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.